Business Context and Reporting Period
This Form 8-K reports on the 2025 Annual Meeting of Stockholders held by LeMaitre Vascular, Inc. on June 2, 2025. The filing details the outcomes of four proposals submitted to security holders, including director elections, executive compensation votes, and the ratification of the independent auditor.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results rather than financial performance data.
Material Changes and Voting Results
As of the record date (April 8, 2025), 22,594,362 shares were entitled to vote, with 21,068,573 shares present. The following matters were approved by a majority of votes cast:
- Election of Directors: Three Class I directors were elected for three-year terms:
- George W. LeMaitre: 18,389,000 votes for; 1,621,733 withheld.
- David B. Roberts: 18,223,556 votes for; 1,787,178 withheld.
- Martha Shadan: 15,217,924 votes for; 4,792,810 withheld.
- Executive Compensation (Say-on-Pay): Approved with 19,060,967 votes for and 913,117 votes against.
- Frequency of Say-on-Pay Votes: Stockholders selected a 1-year frequency (16,990,007 votes) over 2-year (18,302 votes) or 3-year (2,972,329 votes) options.
- Auditor Ratification: Grant Thornton LLP was ratified as the independent registered public accounting firm for 2025 with 21,006,527 votes for and 43,143 votes against.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document is limited to the procedural results of the annual meeting.
Investor Verification Checklist
- Verify the tenure and background of the newly elected directors, particularly noting the significant number of votes withheld for Martha Shadan (approx. 24% of votes cast).
- Confirm the implications of the stockholder preference for annual executive compensation votes.
- Review the full proxy statement for detailed executive compensation data referenced in Proposal No. 2.
- Check subsequent filings for the company's financial results for the fiscal year ending December 31, 2025, as this 8-K contains no financial metrics.